The therapeutic effect of sitagliptin phosphate on type 2 diabetes is very ideal. As a new type of antidiabetic drug, sitagliptin phosphate has the advantages of blood glucose dependence and hypoglyce…
Insulin glargine is an insulin analogue. It replaces one glycine and adds two arginines on the double chains of insulin, thus it is called insulin glargine. The addition of these groups makes the solu…
Insulin glulisine (HMR 1964) is a fast-acting insulin analogue that mimics the pharmacokinetic and pharmacodynamic characteristics of human rational insulin. Insulin glulisine can be used in the resea…
Diabetes is a global chronic metabolic disease that requires lifelong treatment. Under the influence of genetic or environmental factors, if pancreatic B cells are unable to secrete insulin or secrete…
Laipu insulin is a recombinant human insulin analogue and one of the three fast-acting insulin analogues. Insulin Pro can be used in the research of hyperglycemia in diabetes.
Gestational diabetes mellitus (gestationaldiabetesmellitus) can lead to a variety of maternal and infant hazards such as fetal distress, hydramnios, severe cases, even cause miscarriage or stillbirth.…
Insulin glargine is a recombinant human insulin analogue, featuring stability, no peak, and long-lasting action. It has a low solubility in neutral solutions and can be completely dissolved in acidic …
Deter insulin is another new type of soluble long-acting human insulin analogue following insulin glargine. Developed by NovoNordisk, it was launched in Europe in 2004 and approved for the treatment o…
rulicity, a long-acting GLP-1 analogue developed by Eli Lilly for a single subcutaneous injection per week, was approved in the United States in September 2014 for the treatment of type 2 diabetes. St…
Retalutide (LY3437943) is a glucose-dependent insulin-like polypeptide, an agonist of glucagon-like peptide 1 and glucagon receptors. The dose-response relationship in terms of side effects, safety an…
Liraglutide is a transparent and colorless solution. The dosage form is subcutaneous injection. Liraglutide, after more than 10 years of research and development, has numerous functions such as promot…
tirzepatide is a novel glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, also known as gastric inhibitory polypeptide) dual-receptor pathway agonist, admi…
Somallutide is a long-acting dosage form developed based on the basic structure of liraglutide, and it has a better therapeutic effect on type 2 diabetes.
The high and low temperature alternating test chamber is an essential testing equipment in fields such as aviation, automobiles, home appliances, and scientific research. It is used to test and determ…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea